Atazanavir: a novel HIV-1 protease inhibitor

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.9, 2002-09, pp. : 1295-1301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of atazanavir: a novel HIV protease inhibitor

By Fuster Daniel Clotet Bonaventura

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1565-1572

Informa Healthcare

Access to resources Recommend Favorite

Tipranavir: A Novel Nonpeptidic Protease Inhibitor of HIV

By King Jennifer R. Acosta Edward P.

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 665-682

Adis International

Access to resources Recommend Favorite

Atazanavir/ritonavir: a valuable once-daily HIV protease inhibitor with little impact on lipid profile

By Gianotti Nicola Lazzarin Adriano

Future Virology, Vol. 2, Iss. 2, 2007-03 ,pp. : 131-143

Future Medicine

Access to resources Recommend Favorite

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment

By Barragan Patricia Podzamczer Daniel

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2363-2375

Informa Healthcare

Access to resources Recommend Favorite

Dual protease inhibitor therapy in the management of the HIV-1

By Yu K. Daar E.S.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. : 1331-1342

Informa Healthcare

Access to resources Recommend Favorite